Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,111 | -73,726 | -23,554 | -42,967 | -30,639 |
| Depreciation Amortization | 908 | 1,754 | 846 | 1,638 | 808 |
| Accounts receivable | 1,293 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,468 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,890 | 15,456 | 13,190 | 10,736 | 6,192 |
| Other Operating Activity | -19,213 | 35,360 | 3,233 | 17,090 | 4,802 |
| Operating Cash Flow | $-19,765 | $-21,156 | $-6,285 | $-13,503 | $-18,837 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3 | N/A | N/A | N/A | N/A |
| PPE Investments | -170 | -915 | -527 | -355 | -352 |
| Purchase Sale Intangibles | -9 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10 | -118 | -11 | -23 | -5 |
| Investing Cash Flow | $-184 | $-1,033 | $-538 | $-378 | $-357 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,186 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,026 | -5,557 | -2,859 | 50,620 | -2,331 |
| Financing Cash Flow | $-3,213 | $-5,557 | $-2,859 | $50,620 | $-2,331 |
| Exchange Rate Effect | -585 | 102 | 46 | -55 | -20 |
| Beginning Cash Position | 56,461 | 81,464 | 81,072 | 44,794 | 45,129 |
| End Cash Position | 32,714 | 53,820 | 71,436 | 81,479 | 23,584 |
| Net Cash Flow | $-23,747 | $-27,643 | $-9,636 | $36,685 | $-21,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,765 | -21,156 | -6,285 | -13,503 | -18,837 |
| Capital Expenditure | -170 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -19,935 | -21,156 | -6,285 | -13,503 | -18,837 |